featured
Two-Dose mRNA COVID-19 Vaccine Effectiveness in Immunocompromised Adults
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Effectiveness of 2-Dose Vaccination with mRNA COVID-19 Vaccines Against COVID-19-Associated Hospitalizations Among Immunocompromised Adults - Nine States, January-September 2021
MMWR Morb. Mortal. Wkly. Rep. 2021 Nov 05;70(44)1553-1559, PJ Embi, ME Levy, AL Naleway, P Patel, M Gaglani, K Natarajan, K Dascomb, TC Ong, NP Klein, IC Liao, SJ Grannis, J Han, E Stenehjem, MM Dunne, N Lewis, SA Irving, S Rao, C McEvoy, CH Bozio, K Murthy, BE Dixon, N Grisel, DH Yang, K Goddard, AB Kharbanda, S Reynolds, C Raiyani, WF Fadel, J Arndorfer, EA Rowley, B Fireman, J Ferdinands, NR Valvi, SW Ball, O Zerbo, EP Griggs, PK Mitchell, RM Porter, SA Kiduko, L Blanton, Y Zhuang, A Steffens, SE Reese, N Olson, J Williams, M Dickerson, M McMorrow, SJ Schrag, JR Verani, AM Fry, E Azziz-Baumgartner, MA Barron, MG Thompson, MB DeSilvaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.